Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing
Abstract Genomic profiling of hematologic malignancies has augmented our understanding of variants that contribute to disease pathogenesis and supported development of prognostic models that inform disease management in the clinic. Tumor only sequencing assays are limited in their ability to identif...
Similar Items
-
Cell-free DNA from nail clippings as source of normal control for genomic studies in hematologic malignancies
by: Melissa Krystel-Whittemore, et al.
Published: (2024-03-01) -
A deep multiple instance learning framework improves microsatellite instability detection from tumor next generation sequencing
by: John Ziegler, et al.
Published: (2025-01-01) -
Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing
by: Donavan T. Cheng, et al.
Published: (2017-05-01) -
Ultrarapid EGFR Mutation Screening Followed by Comprehensive Next-Generation Sequencing: A Feasible, Informative Approach for Lung Carcinoma Cytology Specimens With a High Success Rate
by: Maria E. Arcila, MD, et al.
Published: (2020-09-01) -
Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings
by: Ozge Ceyhan-Birsoy, et al.
Published: (2024-04-01)